Triumph Capital Management’s HUMANIGEN, INC. HGEN Stock Holding History

Triumph Capital Management’s Portfolio HGEN Stock Details HGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-17,000	Closed	-$3	–	279
2024 Q1	$3	Hold	17,000	–	–	﹤0.01%	225
2023 Q4	$20	Hold	17,000	–	–	﹤0.01%	215
2023 Q3	$219	Hold	17,000	–	–	﹤0.01%	219
2023 Q2	$2.59K	Hold	17,000	–	–	﹤0.01%	223
2023 Q1	$2.44K	Sell	17,000 -40,000	-70%	-$6.4K	﹤0.01%	189
2022 Q4	$6.84K	Buy	57,000 +40,000	+235%	+$5.77K	﹤0.01%	205
2022 Q3	$3K	Buy	+17,000	New	+$9.15K	﹤0.01%	187

Triumph Capital Management's HGEN Position: Q2 2024 in Review

Triumph Capital Management sold out of HUMANIGEN, INC. (HGEN) in Q2 2024, closing a stake of 17,000 shares — an estimated $3 sold.

Triumph Capital Management first reported a position in HGEN in Q3 2022 and held it in 7 quarters. The position peaked at $6.84K in Q4 2022. 0 funds tracked by Wall St. Rank hold HGEN as of Q2 2024.

Triumph Capital Management reported no remaining HUMANIGEN, INC. position as of Q2 2024 after selling out during the quarter.
Triumph Capital Management sold 17,000 HUMANIGEN, INC. shares in Q2 2024, an estimated $3.
Triumph Capital Management first reported a position in HUMANIGEN, INC. in Q3 2022 and held it in 7 quarters.
Triumph Capital Management's HUMANIGEN, INC. position peaked at $6.84K in Q4 2022.
0 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q2 2024.

Based on Triumph Capital Management's 13F filing for Q2 2024, filed 14 Feb 2025.